Mutation Analysis of Epidermal Growth Factor Receptor Gene in Non-Small Cell Lung Cancer for Selection of Patients Eligible for Tyrosine Kinase Inhibitor Therapy
Introduction: Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor therapy is effective as a first-line treatment of advanced non-small-cell lung cancer (NSCLC). This research study investigated the distribution of EGFR mutations in patients diagnosed with NSCLC to assist in selecting...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Shaukat Khanum Memorial Trust
2023-12-01
|
Series: | Journal of Cancer and Allied Specialties |
Subjects: | |
Online Access: | https://journals.sfu.ca/jcas/index.php/jcas/article/view/569 |